PL371340A1 - Sposób wytwarzania kryształów sterydów, kryształydające się otrzymać tym sposobem i ich zastosowanie w preparatach farmaceutycznych - Google Patents

Sposób wytwarzania kryształów sterydów, kryształydające się otrzymać tym sposobem i ich zastosowanie w preparatach farmaceutycznych

Info

Publication number
PL371340A1
PL371340A1 PL03371340A PL37134003A PL371340A1 PL 371340 A1 PL371340 A1 PL 371340A1 PL 03371340 A PL03371340 A PL 03371340A PL 37134003 A PL37134003 A PL 37134003A PL 371340 A1 PL371340 A1 PL 371340A1
Authority
PL
Poland
Prior art keywords
crystals
mum
pharmaceutical formulations
steroid
crystals obtained
Prior art date
Application number
PL03371340A
Other languages
English (en)
Inventor
Detlef Grawe
Hagen Gerecke
Peter Hösel
Annette Eichardt
Sabine Gliesing
Uwe Müller
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of PL371340A1 publication Critical patent/PL371340A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL03371340A 2002-04-23 2003-04-22 Sposób wytwarzania kryształów sterydów, kryształydające się otrzymać tym sposobem i ich zastosowanie w preparatach farmaceutycznych PL371340A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10218107A DE10218107A1 (de) 2002-04-23 2002-04-23 Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen

Publications (1)

Publication Number Publication Date
PL371340A1 true PL371340A1 (pl) 2005-06-13

Family

ID=29264787

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371340A PL371340A1 (pl) 2002-04-23 2003-04-22 Sposób wytwarzania kryształów sterydów, kryształydające się otrzymać tym sposobem i ich zastosowanie w preparatach farmaceutycznych

Country Status (20)

Country Link
US (1) US7148212B2 (pl)
EP (1) EP1497308B1 (pl)
JP (1) JP4490116B2 (pl)
KR (1) KR20040106380A (pl)
CN (1) CN1646555A (pl)
AT (1) ATE340186T1 (pl)
AU (1) AU2003232491A1 (pl)
BR (1) BR0309357A (pl)
CA (1) CA2480004C (pl)
DE (2) DE10218107A1 (pl)
DK (1) DK1497308T3 (pl)
ES (1) ES2274258T3 (pl)
IL (1) IL163986A0 (pl)
MX (1) MXPA04010467A (pl)
NO (1) NO20045023L (pl)
PL (1) PL371340A1 (pl)
PT (1) PT1497308E (pl)
RU (1) RU2315056C2 (pl)
WO (1) WO2003091272A1 (pl)
ZA (1) ZA200409401B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10218109A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
US20080038350A1 (en) * 2006-08-10 2008-02-14 Hagen Gerecke Low-dosage peroral medication for contraception containing crystalline dienogest and ethinyl estradiol
PL1886694T3 (pl) * 2006-08-10 2009-11-30 Jenapharm Gmbh Doustna postać leku do antykoncepcji
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
DE102010003711B4 (de) 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoffpartikel
RU2642244C2 (ru) * 2010-04-12 2018-01-24 Кларус Терапеутикс, Инк. Оральные фармацевтические композиции сложных эфиров тестостерона и способы лечения недостатка тестостерона с их использованием
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
CN106458851B (zh) 2014-05-13 2019-01-11 阿克苏诺贝尔化学品国际有限公司 将螯合剂结晶的方法
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
EP4151219A4 (en) 2020-05-15 2024-05-15 Shionogi & Co., Ltd DRUG COMPOSITION WITH INHIBITED IMPURITIES PRODUCTION

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3226389A (en) 1962-01-04 1965-12-28 Du Pont 11,11,12,12-tetracyano-naphtho-2,6-quinodimethan and its anion-radical salts
AU624421B2 (en) 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
FR2668945B1 (fr) * 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
ES2126976T3 (es) 1991-07-10 1999-04-01 Chiyoda Chem Eng Construct Co Procedimento para la produccion de aducto cristalino de bisfenol a y fenol y aparato para este.
AU660852B2 (en) * 1992-11-25 1995-07-06 Elan Pharma International Limited Method of grinding pharmaceutical substances
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1995018018A1 (en) * 1993-12-27 1995-07-06 Nippon Soda Co. Ltd. 4-hydroxy-4'-isopropoxydiphenyl sulfone developer composition, wet pulverizing method, and dispersion
US5718388A (en) * 1994-05-25 1998-02-17 Eastman Kodak Continuous method of grinding pharmaceutical substances
US5534270A (en) * 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
AU1798300A (en) * 1998-12-25 2000-07-31 Fuji Chemical Industries, Ltd. Method for producing calcium pantothenate
EP1157996A1 (de) * 2000-05-23 2001-11-28 JENAPHARM GmbH Neue Festkörperformen des Mesoprogestins 11Beta-[4E-(Hydroxyiminomethyl)-phenyl]-17Alpha-methoxymethyl-17Beta-methoxy-estra-4,9-dien-3-on
DE10218109A1 (de) * 2002-04-23 2003-11-20 Jenapharm Gmbh Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen

Also Published As

Publication number Publication date
IL163986A0 (en) 2005-12-18
CN1646555A (zh) 2005-07-27
ATE340186T1 (de) 2006-10-15
ZA200409401B (en) 2006-02-22
BR0309357A (pt) 2005-02-22
JP2005524698A (ja) 2005-08-18
EP1497308A1 (de) 2005-01-19
DK1497308T3 (da) 2007-01-29
PT1497308E (pt) 2007-01-31
CA2480004A1 (en) 2003-11-06
EP1497308B1 (de) 2006-09-20
NO20045023L (no) 2004-11-18
RU2004134324A (ru) 2006-02-10
DE10218107A1 (de) 2003-11-20
AU2003232491A1 (en) 2003-11-10
ES2274258T3 (es) 2007-05-16
MXPA04010467A (es) 2004-12-13
CA2480004C (en) 2007-11-13
WO2003091272A1 (de) 2003-11-06
RU2315056C2 (ru) 2008-01-20
JP4490116B2 (ja) 2010-06-23
US7148212B2 (en) 2006-12-12
DE50305122D1 (de) 2006-11-02
KR20040106380A (ko) 2004-12-17
US20030216360A1 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
IL163985A0 (en) Method for the production of crystals, crystals obtained by said method, and use thereof in pharmaceutical formulation
ZA200409401B (en) Method for producing steroid crystals, crystals obtained by said method and their use in pharmaceutical formulations.
MX9603480A (es) Procedimiento para preparar formulaciones farmaceuticas en particulas finas.
HUT46847A (en) Process for producing retarde pharmaceutical compositions of oral application
ZA959308B (en) Pharmaceutical compositions and method of producing the same
ATE313366T1 (de) Vorrichtung und verfahren zur mit ultraschall beaufschlagten strahlkristallisation
ES8505379A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
HUT55382A (en) Process for producing indol derivatives and pharmaceutical compositions containing them as active components
DE69424784D1 (de) Grosse kaliumbicarbonatkristalle und verfahren zu deren herstellung
CA2163111A1 (en) Process for the preparation of an oral solid dosage form containing diclofenac
EP0245929A3 (en) Method of treating phyllosilicates
MXPA05010104A (es) Polvo cristalino de trihidrato de amoxicilina.
WO2003090721A3 (de) Verfahren zur herstellung von kristallen von arzneimittelwirkstoffen und deren verwendung in pharmazeutischen formulierungen
AU2003294055A1 (en) Method for producing particles
CA2212242A1 (en) Stable arylpyrrole particles, process for their preparation and suspension concentrate compositions comprising them
EP1209159A3 (en) Anhydrous mirtazapine and process for preparing the same
JPS53127395A (en) Reculating method for grain size distribution of sodium nitrate
AU1167097A (en) 18-methyl 16-methylene 19-nor pregnane derivatives as progestins, pharmaceutical compositions containing them and process for the preparation thereof
CA2617000A1 (en) Methods for preparing nevirapine hemihydrate and an aqueous suspension thereof
JPS537519A (en) Concentrating method for titanium component
JPS51135278A (en) Method of recovering feed for hens

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)